# US 2005/0032060 A1 · Arrays comprising pre-labeled biological molecules and methods for making and using these arrays

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2005/0032060 A1
- Document ID: US20050032060A1
- Status: Published application
- Kind: A1
- Application number: 10/488,492
- Filed: 2002-08-30
- Published: 2005-02-10
- Earliest claimed: 2001-08-31
- Inventors: Shishir Shah; Mansoor Mohammed
- Web page: https://patentgrep.com/patent/US20050032060A1

## CPC

- C12Q 1/6809: Methods for determination or identification of nucleic acids involving differential detection
- B01J 19/0046: {Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays (synthesis methods per se C40B50/00)}
- B01L 3/508: {Rigid containers without fluid transport within}
- B01J 2219/00576: fluorophore
- B01J 2219/00608: DNA chips
- B01J 2219/0061: The surface being organic
- B01J 2219/00612: the surface being inorganic
- B01J 2219/00621: by physical means, e.g. trenches, raised areas
- B01J 2219/00626: Covalent
- B01J 2219/00641: the porous medium being continuous, e.g. porous oxide substrates
- B01J 2219/00659: Two-dimensional arrays
- B01J 2219/00702: Processes involving means for analysing and characterising the products
- B01J 2219/00722: Nucleotides
- B01L 2300/0636: Integrated biosensor, microarrays
- B01L 2300/0822: Slides
- B01L 2300/10: Means to control humidity and/or other gases
- C12Q 2600/156: Polymorphic or mutational markers
- C40B 40/06: Libraries containing nucleotides or polynucleotides, or derivatives thereof
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)

## Abstract

The invention provides arrays comprising a plurality of biological molecules, wherein each biological molecule is immobilized to a discrete and known spot on a substrate surface to form an array of biological molecules, and each biological molecule comprises a detectable label. The invention provides a multiplexed system for performing comparative genomic hybridization (CGH) using an array of the invention. The invention also provides methods of making and using these arrays, including a method of comparing copy numbers of unique nucleic acid sequences in a sample.

## Claims

### Claim 1

An array comprising a plurality of biological molecules, wherein each biological molecule is immobilized to a discrete and known spot on a substrate surface to form an array of biological molecules, and the biological molecule comprises a detectable label.

### Claim 2 (depends on 1)

The array of claim 1, wherein the plurality of biological molecules comprises a plurality of nucleic acids.

### Claim 3 (depends on 2)

The array of claim 2, wherein the nucleic acid is a DNA or an RNA.

### Claim 4 (depends on 2)

The array of claim 2, wherein the nucleic acid is derived from a human.

### Claim 5 (depends on 2)

The array of claim 2, wherein the plurality of nucleic acids is genomic DNA or is derived from a genomic DNA.

### Claim 6 (depends on 2)

The array of claim 2, wherein the plurality of nucleic acids comprises a plurality of cloned nucleic acid segments.

### Claim 7 (depends on 6)

The array of claim 6, wherein a cloned nucleic acid segment comprises a cloned genomic nucleic acid segment.

### Claim 8 (depends on 7)

The array of claim 7, wherein the cloned genomic nucleic acid segment is free of deletions, as compared to a corresponding wild type genomic nucleic acid segment.

### Claim 9 (depends on 7)

The array of claim 7, wherein the cloned genomic nucleic acid segment is free of additions, as compared to a corresponding wild type genomic nucleic acid segment.

### Claim 10 (depends on 7)

The array of claim 7, wherein the cloned genomic nucleic acid segment is free of additions and deletions, as compared to a corresponding wild type genomic nucleic acid segment.

### Claim 11 (depends on 7)

The array of claim 7, wherein the cloned genomic nucleic acid segment comprises a gene.

### Claim 12 (depends on 6)

The array of claim 6, wherein the cloned nucleic acid comprises a cDNA or a DNA sequence corresponding to or complementary to an RNA message.

### Claim 13 (depends on 12)

The array of claim 12, wherein the message encodes a polypeptide.

### Claim 14 (depends on 7)

The array of claim 7, wherein the spot consists of a cloned nucleic acids segment comprising a single cloned genomic nucleic acid segment.

### Claim 15 (depends on 7)

The array of claim 7, wherein the cloned genomic nucleic acid segments in a first spot is non-overlapping in sequence compared to the cloned genomic nucleic acid segments in a second spot.

### Claim 16 (depends on 15)

The array of claim 15, wherein the cloned genomic nucleic acid segments in a spot is non-overlapping in sequence compared to the cloned genomic nucleic acid segments of other spots on the array.

### Claim 17 (depends on 7)

The array of claim 7, wherein each cloned genomic nucleic acid segment is spotted in duplicate discrete and known spots on the array.

### Claim 18 (depends on 7)

The array of claim 7, wherein the plurality of cloned genomic nucleic acid segments comprises a known segment of a genome.

### Claim 19 (depends on 18)

The array of claim 18, wherein the plurality of known segments of the genome comprises a chromosome.

### Claim 20 (depends on 19)

The array of claim 19, wherein the chromosome comprises a human chromosome.

### Claim 21 (depends on 18)

The array of claim 18, wherein the plurality of known segments of the genome comprises a genome.

### Claim 22 (depends on 21)

The array of claim 21, wherein the genome comprises a human genome.

### Claim 23 (depends on 7)

The array of claim 7, wherein the cloned nucleic acid segment is cloned in a construct comprising an artificial chromosome.

### Claim 24 (depends on 23)

The array of claim 23, wherein the artificial chromosome comprises a bacterial artificial chromosome (BAC).

### Claim 25 (depends on 23)

The array of claim 23, wherein the artificial chromosome is selected from the group consisting of a human artificial chromosome (HAC), a yeast artificial chromosome (YAC), a transformation-competent artificial chromosome (TAC) and a bacteriophage P1-derived artificial chromosome (PAC).

### Claim 26 (depends on 7)

The array of claim 7, wherein the cloned nucleic acid segment is cloned in a construct comprising a vector selected from the group consisting of a cosmid vector, a plasmid vector and a viral vector.

### Claim 27 (depends on 7)

The array of claim 7, wherein the cloned nucleic acid segment is between about 50 kilobases to about 500 kilobases in length.

### Claim 28 (depends on 27)

The array of claim 27, wherein the cloned nucleic acid segment is between about 100 kilobases to about 400 kilobases in length.

### Claim 29 (depends on 28)

The array of claim 28, wherein the cloned nucleic acid segment is about 300 kilobases in length.

### Claim 30 (depends on 1)

The array of claim 1, wherein the detectable label comprises a fluorescent label.

### Claim 31 (depends on 30)

The array of claim 30, wherein the fluorescent label comprises Cy5™ or equivalent.

### Claim 32 (depends on 30)

The array of claim 30, wherein the fluorescent label comprises Cy3™ or equivalent.

### Claim 33 (depends on 30)

The array of claim 30, wherein the fluorescent label comprises a rhodamine, a fluorescein or an aryl-substituted 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene dye or equivalents.

### Claim 34 (depends on 1)

The array of claim 1, wherein the detectable label comprises a nucleic acid stem-loop structure.

### Claim 35 (depends on 34)

The array of claim 34, wherein the nucleic acid stem-loop structure comprises a molecular beacon structure.

### Claim 36 (depends on 34)

The array of claim 34, wherein the nucleic acid stem-loop structure comprises an aptamer beacon structure.

### Claim 37 (depends on 1)

The array of claim 1, wherein the biological molecule is covalently bound to the detectable label.

### Claim 38 (depends on 1)

The array of claim 1, wherein the immobilized biological molecules comprise the same detectable label.

### Claim 39 (depends on 1)

The array of claim 1, wherein about 50% of the immobilized biological molecules comprise a detectable label.

### Claim 40

(canceled)

### Claim 41

(canceled)

### Claim 42 (depends on 39)

The array of claim 39, wherein about 80% of the array-immobilized biological molecules comprise a detectable label.

### Claim 43

(canceled)

### Claim 44

(canceled)

### Claim 45

(canceled)

### Claim 46 (depends on 39)

The array of claim 39, wherein about 99% of the array-immobilized biological molecules comprise a detectable label.

### Claim 47

(canceled)

### Claim 48 (depends on 1)

The array of claim 1, wherein the biological molecule is covalently bound to the substrate surface.

### Claim 49 (depends on 48)

The array of claim 48, wherein the biological molecule is covalently bound to a compound having the general formula: R1—X—R2, wherein R1 is a cyclic ether, an aldehyde, or a chloromethylphenyl moiety; X is a moiety chemically suitable for linking the R1 moiety to the R2 moiety, and the R2 moiety has the general formula
wherein R3, R4 and R5 comprise identical or different alkoxy group or chloro groups.

### Claim 50 (depends on 49)

The array of claim 49, wherein the cyclic ether is an epoxide group.

### Claim 51 (depends on 50)

The array of claim 50, wherein the epoxide group is an epoxycyclohexyl group or epoxycyclopentyl group.

### Claim 52 (depends on 49)

The array of claim 49, wherein the R2 moiety comprises an alkoxysilane group.

### Claim 53 (depends on 49)

The array of claim 49, wherein the R2 moiety is selected from the group consisting of a methoxyethoxy group, a —OCH2CH2OCH3 group, a chlorohalide group and a propoxy group.

### Claim 54 (depends on 49)

The array of claim 49, wherein R1—X—R2 compound is selected from the group consisting of (3-glycidoxypropyl) methyldiethoxysilane, (3-glycidoxypropyl)methyldiisopropenoxysilane; 2-(3,4-epoxycyclohexyl) ethyltrimethoxysilane and (3-glycidoxypropyl)dimethylethoxysilane.

### Claim 55 (depends on 1)

The array of claim 1, wherein the biological molecule is covalently bound to a compound having the general formula: R1—X—R2, wherein R1 is an amino group, R2 is an alkoxysilane group or a chlorohalide group; and X is a moiety chemically suitable for linking the R1 group and the R2 group.

### Claim 56 (depends on 1)

The array of claim 1, wherein the biological molecule is covalently bound to a compound having the general formula
R1—X—Si(OR2)m(Cl)n(R)k,
wherein m+k is the integer 3, and n can be 0 if m is greater than 0, or n+k is the integer 3 and m can be 0 if n is greater than 0; X is an inert linker; R1 comprises a group reactive toward the biological molecule; R is an alkyl group; and, R2 is an alkyl group.

### Claim 57

An array comprising a plurality of bacterial artificial chromosomes (BACs), wherein each bacterial artificial chromosome is immobilized to a discrete and known spot on a substrate surface to form an array of bacterial artificial chromosomes (BACs), and each bacterial artificial chromosome comprises a detectable label.

### Claim 58 (depends on 57)

The array of claim 57, wherein the array comprises a SpectralChip™ Mouse BAC Array.

### Claim 59 (depends on 57)

The array of claim 57, wherein the array comprises a SpectralChip™ Human BAC Array.

### Claim 60

A method of making an array, wherein the array comprises a plurality of genomic nucleic acids covalently labeled with a compound comprising a fluorescent label, comprising
labeling the plurality of genomic nucleic acid segments, wherein the segments have lengths averaging between about 50 kilobases and about 500 kilobases or are fragmented or digested to have lengths averaging between about 50 kilobases and about 500 kilobases, with a fluorescent label; and
immobilizing the labeled nucleic acids to discrete and known spots on a substrate surface to form an array of nucleic acids.

### Claim 61 (depends on 60)

The method of claim 60, wherein a cloned nucleic acid segment is cloned in a construct comprising an artificial chromosome.

### Claim 62 (depends on 61)

The method of claim 61, wherein the artificial chromosome comprises a bacterial artificial chromosome (BAC).

### Claim 63 (depends on 61)

The method of claim 61, wherein the artificial chromosome is selected from the group consisting of a human artificial chromosome (HAC), a yeast artificial chromosome (YAC), a transformation-competent artificial chromosome (TAC) and a bacteriophage P1-derived artificial chromosome (PAC).

### Claim 64 (depends on 60)

The method of claim 60, wherein the detectable label comprises a fluorescent label.

### Claim 65 (depends on 64)

The method of claim 64, wherein the fluorescent label comprises Cy5™ or equivalent.

### Claim 66 (depends on 64)

The method of claim 64, wherein the fluorescent label comprises Cy3™ or equivalent.

### Claim 67 (depends on 64)

The method of claim 64, wherein the fluorescent label comprises a rhodamine, a fluorescein or an aryl-substituted 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene dye or equivalents.

### Claim 68 (depends on 60)

The method of claim 60, wherein labeling of the genomic nucleic acid segments comprises labeling by random primer extension.

### Claim 69 (depends on 60)

The method of claim 60, wherein labeling of the genomic nucleic acid segments comprises nick translation labeling.

### Claim 70

A method of performing comparative genomic hybridization (CGH) using an array comprising a plurality of genomic nucleic acids covalently labeled with a compound comprising a detectable label, comprising:
contacting an array comprising a plurality of cloned genomic nucleic acid segments, wherein each genomic nucleic acid segment is immobilized to a discrete and known spot on a substrate surface to form an array, and the genomic nucleic acid segments comprise a first detectable label, with a sample comprising a plurality of genomic nucleic acid segments, wherein the sample genomic nucleic acid segments are labeled with at least a second detectable label; under conditions wherein the nucleic acid in the sample can specifically hybridize to the genomic nucleic acid segments and
measuring an amount of the first and the second fluorescent label on each spot, thereby performing comparative genomic hybridization.

### Claim 71 (depends on 70)

The method of claim 70, wherein a cloned nucleic acid segment is cloned in a construct comprising an artificial chromosome.

### Claim 72 (depends on 70)

The method of claim 70, wherein the artificial chromosome comprises a bacterial artificial chromosome (BAC).

### Claim 73 (depends on 70)

The method of claim 70, wherein the detectable label comprises a fluorescent label.

### Claim 74 (depends on 73)

The method of claim 73, wherein the fluorescent label comprises Cy5™ or equivalent.

### Claim 75 (depends on 73)

The method of claim 73, wherein the fluorescent label comprises Cy3™ or equivalent.

### Claim 76 (depends on 73)

The method of claim 73, wherein the fluorescent label comprises a rhodamine, a fluorescein or an aryl-substituted 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene dye or equivalents.

### Claim 77

A method of comparing copy numbers of unique nucleic acid sequences in a first sample comprising nucleic acid sequences of a first cell or cell population relative to copy numbers of substantially identical sequences in at least a second sample comprising nucleic acid sequences of at least a second cell or cell population, wherein the nucleic acids of the first sample comprise a first detectable label, and the nucleic acids of the second sample comprise a second detectable label, said method comprising:
contacting an array comprising the nucleic acid sequences of the first sample, wherein the nucleic acid sequences of the first sample are immobilized to discrete and known spots on a substrate surface to form an array, with a second sample comprising nucleic acid sequences of the second sample; under conditions wherein the nucleic acid sequences in the second sample can specifically hybridize to the immobilized nucleic acid sequences of the first sample; and
comparing the intensities of the signals from the nucleic acids sequences of the second sample to the nucleic acid sequences of the second sample, thereby comparing copy numbers of unique nucleic acid sequences in the first sample compared to the second sample.

### Claim 78

A multiplexed system for performing comparative genomic hybridization (CGH) using an array comprising:
the array comprising a plurality of biological molecules, wherein the biological molecule is immobilized to a discrete and known spot on a substrate surface to form the array of biological molecules, and each biological molecule comprises a first detectable label;
a device for detecting the immobilized first detectable label and at least a second detectable label, wherein the device can measure the first and the second detectable labels on the spots on the substrate surface.

### Claim 79 (depends on 78)

The multiplexed system of claim 78, wherein the device comprises a charge-coupled device (CCD).

### Claim 80 (depends on 78)

The multiplexed system of claim 78, wherein the device is capable of multicolor fluorescence imaging.

### Claim 81 (depends on 78)

The multiplexed system of claim 78, further comprising a computer processor to analyze multicolor fluorescence imaging data.
